Perakakis N, Bornstein SR, Birkenfeld AL, Linkermann A, et al. Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis. Diabetes Obes Metab 2023 Oct 10. doi: 10.1111/dom.15305.
PMID: 37814928